BRISTOL, Tenn.--(BUSINESS WIRE)--Graceway Pharmaceuticals, LLC today announced that Health Canada has approved ZyclaraTM (imiquimod) Cream 3.75% for the treatment of multiple actinic keratosis (AK) of the face or balding scalp in adults with normal immune systems.
